1- Elshoury A, Przespolewski A, Baron J, Wang ES. Advancing treatment of acute myeloid leukemia: the future of FLT3 inhibitors. Expert Rev Anticancer Ther. 2019 Mar;19(3):273-286
2-Elshoury Amro, Wallace PK, Borowitz MJ, Kader A, Choi C, Ho C, Balderman S, Ross M, Hahn T, O'Neill V, McCarthy PL, Chen GL. BPX-501 T cells interfere with minimal residual disease evaluation of B-cell acute lymphoblastic leukemia. Bone Marrow Transplant. 2018 ;53(5):651-653
3-Elshoury A, Baron J, Przespolewski A, Wang E. Optimizing FLT3 Inhibitor Monotherapy in Acute Myeloid Leukemia. The journal of targeted therapies in cancer. 2017 December.
4- Przespolewski A, Szeles, Elshoury A, Wang E. Chimeric Antigen Receptor T-Cell Therapy in Acute Myeloid Leukemia. Targeted oncology. 2017 October 25
5- Abdel-Azim H, Elshoury A, Mahadeo KM, Parkman R, Kapoor N. Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution. Biol Blood Marrow Transplant. 2017 Sep;23(9):1437-1446.